Items where Author is "Cloatre, Emilie"
![[up]](/style/images/multi_up.png)
Up a levelCloatre, Emilie and Pickersgill, Martyn and Atuire, Caesar A. and Enright, Mairead and Friesen, Phoebe and Ndoye, Tidiane and Urquiza-Haas, Nayeli (2025) States, law, and the regulation of controversial health claims : consolidating a research agenda between disciplines and contexts. Wellcome Open Research: 414. ISSN 2398-502X
Urquiza-Haas, Nayeli and Cloatre, Emilie (2023) In the shadow of the healing rainbow : belonging and identity in the regulation of traditional medicine in Mauritius. Griffith Law Review, 32 (2). pp. 236-258. ISSN 1038-3441
Urquiza-Haas, Nayeli and Cloatre, Emilie (2022) Tradition and reinvention : the making and unmaking of herbal medicines in the UK. Journal of Law and Society, 49 (2). pp. 317-338. ISSN 0263-323X
Cloatre, Emilie and Urquiza-Haas, Nayeli (2022) Misdirection and the Regulation of Herbalism in France and England. Science & Technology Studies, 35 (2). pp. 30-51.
Urquiza, Nayeli and Cloatre, Emilie (2021) The Challenge of ‘Evidence’ : Research and Regulation of Traditional and Non-Conventional Medicines. In: The Cambridge Handbook of Health Research Regulation :. Cambridge University Press, Cambridge, pp. 296-305. ISBN 9781108620024
Cloatre, Emilie and Urquiza-Haas, Nayeli and Ashworth, Michael (2021) Legalities of Healing : Handling Alterities at the Edge of Medicine in France, 1980s–2010s. Osiris, 36. pp. 328-348. ISSN 0369-7827
Cloatre, Emilie and Urquiza-Haas, Nayeli (2020) Correction to : Healthcare, Well-being, and the Regulation of Diversity in Healing (A Jurisprudence of the Body, Palgrave Socio-Legal Studies, https://doi.org/10.1007/978-3-030-42200-4_5). Palgrave Socio-Legal Studies. C1. ISSN 2947-9274
Cloatre, Emilie and Urquiza, Nayeli (2020) Healthcare, Well-being, and the Regulation of Diversity in Healing. In: Palgrave Socio-Legal Studies :. Palgrave Socio-Legal Studies . UNSPECIFIED, pp. 91-116. ISBN 9783030421991
Urquiza-Haas, Nayeli and Cloatre, Emilie (2019) Traditional herbal medicine and the challenges of pharmacovigilance. UNSPECIFIED.